Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 84

Inside the human eye, the retina is made up of several types of cells, including the light-sensing photoreceptors that initiate the cascade of events that lead to vision. Damage to the photoreceptors, either through degenerative disease or injury, leads to permanent vision impairment or blindness.

David Gamm, director of UW–Madison’s McPherson Eye Research Institute and professor of ophthalmology and visual sciences, says that stem cell replacement therapy using lab-grown photoreceptors is a promising strategy to combat retinal disease. The challenge is that stem cell treatments aimed at replacing photoreceptors need to first be tested in animals. Since human cells are not compatible in other species and are quickly rejected when transplanted, it’s difficult to assess their potential.

Pig and human retinas share many key features, making pigs ideal for modeling human retinal disease and testing ocular therapeutics. By testing ‘human-equivalent’ photoreceptors in pigs, we can get a better sense of what these cells can do if they are not immediately attacked by the host animal.

Read more | >

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreatic cancer at bay in preclinical models for significantly longer than the same targeted therapy by itself, according to researchers from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine’s Abramson Cancer Center. The results, published in Cancer Discovery, prime the combination strategy for future clinical trials.

Patients with pancreatic cancer have an overall poor prognosis: in most patients, the disease has already spread at the time of diagnosis, resulting in limited treatment options. Nearly 90 percent of pancreatic cancers are driven by KRAS mutations, the most common cancer-causing gene mutation across cancer types, which researchers long considered “undruggable.”

In 2021, the first KRAS inhibitor was approved to treat with KRAS G12C mutations, but with longer follow-up, it has become clear that KRAS-mutant cancers can quickly evolve to resist therapies targeted at one specific form of the gene mutation.

Read more | >

Researchers at the TechMed Center of the University of Twente and Radboud University Medical Center have removed blood clots with wireless magnetic robots. This innovation promises to transform treatment for life-threatening vascular conditions like thrombosis.

Cardiovascular diseases such as thrombosis are a major global health challenge. Each year worldwide, 1 in 4 people die from conditions caused by blood clots. A blood clot blocks a blood vessel, preventing the blood from delivering oxygen to certain areas of the body.

Minimally invasive Traditional treatments struggle with clots in hard-to-reach areas. But magnetic microrobots bring hope to patients with otherwise inoperable clots. The screw-shaped robots can navigate through intricate vascular networks since they are operated wirelessly.

Read more | >

In the spring of 2022, Tim Story’s doctor told him that he likely had just months to live. Story, a high school football coach in Hattiesburg, Mississippi, had been diagnosed with Stage 3 small bowel cancer two years earlier, at the age of 49, after mysterious pains in his side turned out to be a tumor in his small intestine. Surgery and several grueling rounds of chemotherapy and immunotherapy had failed to stop the cancer, which had spread to other organs.

Read more | >

— Kreiner, et al.

In this article, the authors review the current understanding of obesity-related kidney disease and focus on the intertwined cardiometabolic abnormalities, which, in addition to obesity and diabetes, include risk factors such as hypertension, dyslipidemia, and systemic inflammation.

Full text is available

Obesity is a serious chronic disease and an independent risk factor for the new onset and progression of chronic kidney disease (CKD). CKD prevalence is expected to increase, at least partly due to the continuous rise in the prevalence of obesity. The concept of obesity-related kidney disease (OKD) has been introduced to describe the still incompletely understood interplay between obesity, CKD, and other cardiometabolic conditions, including risk factors for OKD and cardiovascular disease, such as diabetes and hypertension. Current therapeutics target obesity and CKD individually. Non-pharmacological interventions play a major part, but the efficacy and clinical applicability of lifestyle changes and metabolic surgery remain debatable, because the strategies do not benefit everyone, and it remains questionable whether lifestyle changes can be sustained in the long term.

Read more | >

University of Illinois at Urbana-Champaign researchers have developed a CRISPR-based diagnostic tool capable of detecting bloodstream infections in minutes without the need for nucleic acid amplification. The CRISPR-Cascade assay achieves attomolar sensitivity and incorporates an OR-gated logic function to identify multiple pathogens simultaneously through DNA from pathogens associated with bloodstream infections.

Bloodstream infections require rapid identification to prevent complications, yet standard diagnostic methods rely on (PCR) and isothermal amplification techniques that have built-in processing times. CRISPR-based detection tools such as SHERLOCK and DETECTR have improved specificity but continue to depend on amplification, limiting their turnaround time and practicality in clinical settings.

In the study, “Amplification-free, OR-gated CRISPR-Cascade reaction for pathogen detection in blood samples,” published in the Proceedings of the National Academy of Sciences, researchers conducted a laboratory-based investigation to determine whether a CRISPR-driven feedback loop could detect pathogenic DNA at ultra-low concentrations without amplification.

Read more | >

Researchers have advanced a decades-old challenge in the field of organic semiconductors, opening new possibilities for the future of electronics. The researchers, led by the University of Cambridge and the Eindhoven University of Technology, have created an organic semiconductor that forces electrons to move in a spiral pattern, which could improve the efficiency of OLED displays in television and smartphone screens, or power next-generation computing technologies such as spintronics and quantum computing.

The semiconductor they developed emits circularly polarized light—meaning the light carries information about the ‘handedness’ of electrons. The internal structure of most inorganic semiconductors, like silicon, is symmetrical, meaning electrons move through them without any preferred direction.

However, in nature, molecules often have a chiral (left-or right-handed) structure: like human hands, are mirror images of one another. Chirality plays an important role in like DNA formation, but it is a difficult phenomenon to harness and control in electronics.

Read more | >

A major breakthrough in organic semiconductors.

Semiconductors are materials with electrical conductivity that falls between conductors and insulators, making them essential for modern electronics. They are typically crystalline solids, the most common of which is silicon, used extensively in the production of electronic components such as transistors and diodes. Semiconductors are unique because their conductivity can be altered and controlled through doping—adding impurities to the material to change its electrical properties. This property allows them to serve as the foundation for integrated circuits and microchips, powering everything from computers and smartphones to advanced medical devices and renewable energy technologies. The behavior of semiconductors is also crucial in the development of various electronic, photonic, and quantum devices.

Read more | >